Page last updated: 2024-09-05

tak 779 and flupenthixol

tak 779 has been researched along with flupenthixol in 1 studies

Compound Research Comparison

Studies (tak 779)	Trials (tak 779)	Recent Studies (post-2010) (tak 779)	Studies (flupenthixol)	Trials (flupenthixol)	Recent Studies (post-2010) (flupenthixol)
118	1	35	929	128	138

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berman, JW; Gaskill, PJ; Javitch, JA; Kalpana, GV; Yano, HH	1

Other Studies

1 other study(ies) available for tak 779 and flupenthixol

Article	Year
Dopamine receptor activation increases HIV entry into primary human macrophages. PloS one, 2014, Volume: 9, Issue:9 Topics: Amides; CCR5 Receptor Antagonists; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Flupenthixol; Gene Expression; HIV Fusion Inhibitors; HIV-1; Humans; Macrophages; Primary Cell Culture; Quaternary Ammonium Compounds; Receptors, CCR5; Receptors, Dopamine D1; Receptors, Dopamine D2; Virus Internalization	2014

Article

Year

Dopamine receptor activation increases HIV entry into primary human macrophages.

PloS one, 2014, Volume: 9, Issue:9

Topics: Amides; CCR5 Receptor Antagonists; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Flupenthixol; Gene Expression; HIV Fusion Inhibitors; HIV-1; Humans; Macrophages; Primary Cell Culture; Quaternary Ammonium Compounds; Receptors, CCR5; Receptors, Dopamine D1; Receptors, Dopamine D2; Virus Internalization

2014